1. Home
  2. MAMK vs GANX Comparison

MAMK vs GANX Comparison

Compare MAMK & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAMK
  • GANX
  • Stock Information
  • Founded
  • MAMK 2007
  • GANX 2017
  • Country
  • MAMK China
  • GANX United States
  • Employees
  • MAMK N/A
  • GANX N/A
  • Industry
  • MAMK Apparel
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAMK Consumer Discretionary
  • GANX Health Care
  • Exchange
  • MAMK Nasdaq
  • GANX Nasdaq
  • Market Cap
  • MAMK 43.2M
  • GANX 51.8M
  • IPO Year
  • MAMK 2025
  • GANX 2021
  • Fundamental
  • Price
  • MAMK $2.47
  • GANX $1.48
  • Analyst Decision
  • MAMK
  • GANX Strong Buy
  • Analyst Count
  • MAMK 0
  • GANX 5
  • Target Price
  • MAMK N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • MAMK 615.1K
  • GANX 283.4K
  • Earning Date
  • MAMK 01-01-0001
  • GANX 08-19-2025
  • Dividend Yield
  • MAMK N/A
  • GANX N/A
  • EPS Growth
  • MAMK N/A
  • GANX N/A
  • EPS
  • MAMK 0.12
  • GANX N/A
  • Revenue
  • MAMK $21,434,100.00
  • GANX N/A
  • Revenue This Year
  • MAMK N/A
  • GANX N/A
  • Revenue Next Year
  • MAMK N/A
  • GANX N/A
  • P/E Ratio
  • MAMK $20.43
  • GANX N/A
  • Revenue Growth
  • MAMK N/A
  • GANX N/A
  • 52 Week Low
  • MAMK $2.28
  • GANX $0.89
  • 52 Week High
  • MAMK $4.00
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • MAMK N/A
  • GANX 41.72
  • Support Level
  • MAMK N/A
  • GANX $1.41
  • Resistance Level
  • MAMK N/A
  • GANX $1.68
  • Average True Range (ATR)
  • MAMK 0.00
  • GANX 0.12
  • MACD
  • MAMK 0.00
  • GANX -0.00
  • Stochastic Oscillator
  • MAMK 0.00
  • GANX 14.29

About MAMK MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: